| Huntington disease NS Caron, GEB Wright, MR Hayden GeneReviews®[Internet], 2020 | 190* | 2020 |
| Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ... The American Journal of Human Genetics 104 (6), 1116-1126, 2019 | 158 | 2019 |
| Nuclear receptor NR1H3 in familial multiple sclerosis Z Wang, AD Sadovnick, AL Traboulsee, JP Ross, CQ Bernales, ... Neuron 90 (5), 948-954, 2016 | 117 | 2016 |
| Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright Current Pharmacogenomics and Personalized Medicine 9 (3), 191-207, 2011 | 89 | 2011 |
| Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS ABP van Kuilenburg, M Tarailo-Graovac, PA Richmond, BI Drögemöller, ... New England Journal of Medicine 380 (15), 1433-1441, 2019 | 83 | 2019 |
| The global spectrum of protein-coding pharmacogenomic diversity GEB Wright, B Carleton, MR Hayden, CJD Ross The Pharmacogenomics Journal 18, 187–195, 2018 | 78 | 2018 |
| Ethical and legal implications of whole genome and whole exome sequencing in African populations GEB Wright, PGJ Koornhof, AA Adeyemo, N Tiffin BMC Medical Ethics 14 (1), 21, 2013 | 78 | 2013 |
| The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population C Kay, JA Collins, GEB Wright, F Baine, Z Miedzybrodzka, F Aminkeng, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018 | 69 | 2018 |
| Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ... Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019 | 67 | 2019 |
| Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population GEB Wright, DJH Niehaus, BI Drögemöller, L Koen, A Gaedigk, L Warnich Annals of Human Genetics 74 (4), 340-350, 2010 | 65 | 2010 |
| Characterization of the genetic profile of CYP2C19 in two South African populations BI Drögemöller, GEB Wright, DJH Niehaus, L Koen, S Malan, DM Da Silva, ... Pharmacogenomics 11 (8), 1095-1103, 2010 | 62 | 2010 |
| Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ... JAMA Oncology 3 (11), 1558-1562, 2017 | 57 | 2017 |
| Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies GEB Wright, HF Black, JA Collins, T Gall-Duncan, NS Caron, CE Pearson, ... The Lancet Neurology 19 (11), 930-939, 2020 | 55 | 2020 |
| SJS/TEN 2019: from science to translation WC Chang, R Abe, P Anderson, W Anderson, MR Ardern-Jones, ... Journal of dermatological science 98 (1), 2-12, 2020 | 53 | 2020 |
| Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study TM Dodgen, WE Hochfeld, H Fickl, SM Asfaha, C Durandt, P Rheeder, ... BMC Medical Genetics 14 (1), 20, 2013 | 53 | 2013 |
| Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients M McCormack, H Gui, A Ingason, D Speed, GEB Wright, EJ Zhang, ... Neurology 90 (4), e332-e341, 2018 | 49 | 2018 |
| Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients BI Drögemöller, B Brooks, C Critchley, JG Monzon, GEB Wright, G Liu, ... Clinical Cancer Research 24 (8), 1866-1871, 2018 | 45 | 2018 |
| Characterization of the genetic variation present in CYP3A4 in three South African populations BI Drögemöller, M Plummer, L Korkie, G Agenbag, A Dunaiski, D Niehaus, ... Frontiers in Genetics 4, 17, 2013 | 45 | 2013 |
| Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range HF Black, GEB Wright, JA Collins, N Caron, C Kay, Q Xia, L Arning, ... Genetics in Medicine 22 (12), 2108-2113, 2020 | 40 | 2020 |
| Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment BI Drögemöller, GEB Wright, DJH Niehaus, R Emsley, L Warnich Pharmacogenetics and Genomics 23 (12), 666-674, 2013 | 40 | 2013 |
Colin RossUniversity of British ColumbiaVerified email at ubc.ca
